Erle T. Mast, Executive VP and CFO at Clovis Oncology, Inc. (CLVS), bought 7,701 shares at $13.00 ($69K) on 2011-11-21, disclosed to the SEC on 2011-11-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,378 | $0 | 0.0% |
| 2 | $13.00 | 5,323 | $69K | 100.0% |
| Total | $8.99 avg | 7,701 | $69K | 100% |
| Filing → |
| SNNA | BUY | 2017-08-01 | $101K | — | Filing → |
| CLVS | SELL | 2015-11-03 | $317K | — | Filing → |
| CLVS | SELL | 2015-10-02 | $271K | — | Filing → |